Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 34 results:
Author [ Title] Type Year Filters: Author is Papademetriou, Vasilios [Clear All Filters]
Arterial Stiffness and Emerging Biomarkers: Still a Long Journey to Go..
Angiology. 66(10), 901-3.
(2015). Benefits from treatment and control of patients with resistant hypertension..
Int J Hypertens. 2011, 318549.
(2010). Carotid baroreceptor stimulation as a therapeutic target in hypertension and other cardiovascular conditions..
Expert Opin Ther Targets. 13(4), 413-25.
(2009). Carotid baroreceptor stimulation for the treatment of resistant hypertension..
Int J Hypertens. 2011, 964394.
(2011). Chronic Kidney Disease, Basal Insulin Glargine, and Health Outcomes in People with Dysglycemia: The ORIGIN Study..
Am J Med. 130(12), 1465.e27-1465.e39.
(2017). Determinants of pulse wave velocity index and potential implementations..
J Clin Hypertens (Greenwich).
(2019). Dynamic resistant hypertension patterns as predictors of cardiovascular morbidity: a 4-year prospective study..
J Hypertens. 32(2), 415-22.
(2014).
(2017).
Effect of renal sympathetic denervation on short-term blood pressure variability in resistant hypertension: a meta-analysis..
J Hypertens. 35(9), 1750-1757.
(2017). Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment: The Action to Control Cardiovascular Risk in Diabetes Study..
Am J Nephrol. 45(2), 136-145.
(2017). Exercise capacity and mortality in older men: a 20-year follow-up study..
Circulation. 122(8), 790-7.
(2010). Gender differences in hypertension: myths and reality..
Curr Hypertens Rep. 15(4), 321-30.
(2013). A graded association of exercise capacity and all-cause mortality in males with high-normal blood pressure..
Blood Press. 18(5), 261-7.
(2009). Important practice lessons from the SPRINT study beyond the blood pressure goal: all well known and now confirmed..
J Am Soc Hypertens. 10(8), 613-7.
(2016). Insomnia and hypertension: A misty landscape..
J Clin Hypertens (Greenwich). 21(6), 835-837.
(2019). Left ventricular hypertrophy as a determinant of renal outcome in patients with high cardiovascular risk..
J Hypertens. 28(11), 2299-308.
(2010). Non-interventional management of resistant hypertension..
World J Cardiol. 6(10), 1080-90.
(2014). Non-pharmacological Modulation of the Autonomic Nervous System for Heart Failure Treatment: Where do We Stand?.
Curr Vasc Pharmacol. 16(1), 30-43.
(2017). Psoriasis and Cardiovascular Disease: Two Sides of the Same Coin?.
Angiology. 69(1), 5-9.
(2018). Renal and cardiac effects of renal sympathetic denervation and carotid baroreceptor stimulation..
Curr Vasc Pharmacol. 12(1), 55-62.
(2014). Renal denervation and Symplicity HTN-3: "Dubium sapientiae initium" (doubt is the beginning of wisdom)..
Circ Res. 115(2), 211-4.
(2014). Renal Denervation Therapy: Can it Contribute to Better Blood Pressure Control in Hypertension?.
Curr Vasc Pharmacol. 16(1), 66-69.
(2017). Renal Denervation Therapy for Drug-Resistant Hypertension: Does It Still Work?.
Curr Treat Options Cardiovasc Med. 19(5), 39.
(2017). Renal nerve ablation for resistant hypertension: how did we get here, present status, and future directions..
Circulation. 129(13), 1440-51.
(2014). Renal nerve ablation for resistant hypertension: the dust has not yet settled..
J Clin Hypertens (Greenwich). 16(6), 399-400.
(2014).